Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-23 Sale |
2025-01-27 8:28 pm |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
55,000 | $40.25 | $2,213,997 | 100,700 (Indirect Direct) |
View |
| 2024-12-18 Sale |
2024-12-19 6:57 pm |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
18,709 | $41.21 | $770,912 | 6,000 (Direct) |
View |
| 2024-11-22 Sale |
2024-11-22 7:48 pm |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
4,891 | $41.08 | $200,947 | 28,475 (Indirect Direct) |
View |
| 2024-03-08 Sale |
2024-03-11 8:09 pm |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
2,092 | $45.69 | $95,583 | 16,500 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-08 5:31 pm |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
7,137 | $46.28 | $330,290 | 8,398 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-08 5:28 pm |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
13,000 | $46.28 | $601,615 | 2,000 (Direct) |
View |
| 2023-12-14 Sale(A) |
2023-12-15 9:50 pm |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
7,598 | $41.05 | $311,898 | 4,902 (Indirect) |
View |
| 2023-12-13 Sale |
2023-12-15 5:38 pm |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
18,978 | $39.99 | $758,983 | 28,475 (Indirect Direct) |
View |
| 2023-08-24 Sale |
2023-08-24 4:33 pm |
Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director |
25,000 | $38.7 | $967,500 | 25,000 (Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 7:25 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
131,245 | $38.9 | $5,104,970 | 81,682 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-12 Option Award |
2025-03-13 7:33 pm |
N/A 2035-03-11 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
325,000 | $0 | 325,000 (Direct) |
View |
| 2025-03-12 Option Award |
2025-03-13 7:31 pm |
N/A 2035-03-11 |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2025-03-12 Option Award |
2025-03-13 7:30 pm |
N/A 2035-03-11 |
Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 8:28 pm |
N/A 2025-03-16 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
55,000 | $0 | 100,700 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 8:28 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
55,000 | $17.76 | 100,700 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-19 6:57 pm |
N/A 2029-09-15 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
25,334 | $0 | 6,000 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-19 6:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
9,334 | $9.44 | 6,000 (Direct) |
View |
| 2024-12-18 Tax Withholding |
2024-12-19 6:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
6,625 | $41.28 | 6,000 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-19 6:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
16,000 | $11.58 | 6,000 (Direct) |
View |
| 2024-11-22 Exercise |
2024-11-22 7:48 pm |
N/A 2026-06-01 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
6,586 | $0 | 28,475 (Direct) |
View |
| 2024-11-22 Tax Withholding |
2024-11-22 7:48 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
1,695 | $39.8 | 28,475 (Direct) |
View |
| 2024-11-22 Exercise |
2024-11-22 7:48 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
3,500 | $7.38 | 28,475 (Direct) |
View |
| 2024-11-22 Exercise |
2024-11-22 7:48 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
3,086 | $13.48 | 28,475 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:43 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:42 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:42 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:42 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:42 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:41 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 5:41 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:42 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:41 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:38 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:37 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 65,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:35 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
65,000 | $0 | 65,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:34 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:33 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-11 8:09 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
3,500 | $0 | 16,500 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-11 8:09 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
3,500 | $18.56 | 16,500 (Direct) |
View |
| 2024-03-08 Tax Withholding |
2024-03-11 8:09 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
1,408 | $46.16 | 16,500 (Direct) |
View |
| 2024-03-07 Exercise |
2024-03-08 5:31 pm |
N/A 2024-03-11 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
8,641 | $0 | 8,398 (Direct) |
View |
| 2024-03-07 Exercise |
2024-03-08 5:31 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
8,641 | $9.85 | 8,398 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-08 5:31 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
1,504 | $45.96 | 8,398 (Direct) |
View |
| 2023-12-29 Other |
2024-01-02 4:41 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
8,398 | $0 | 16,796 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-20 5:04 pm |
2016-12-31 2024-01-13 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
4,320 | $0 | 74,225 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-20 5:04 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
4,320 | $9.85 | 74,225 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 5:38 pm |
2016-12-31 2024-01-13 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
14,322 | $0 | 28,475 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 5:38 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
9,258 | $9.85 | 28,475 (Direct) |
View |
| 2023-12-13 Tax Withholding |
2023-12-15 5:38 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
3,022 | $39.68 | 28,475 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 5:38 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
5,144 | $9 | 28,475 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-10 7:05 pm |
N/A 2033-08-09 |
Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director |
28,000 | $0 | 28,000 (Direct) |
View |
Ownership |
2023-08-10 7:00 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director |
0 | $0 | 0 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-10 6:56 pm |
N/A 2033-08-09 |
Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director |
28,000 | $0 | 28,000 (Direct) |
View |
Ownership |
2023-08-10 6:40 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director |
0 | $0 | 0 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:29 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:27 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:25 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:24 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:22 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:21 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:20 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 7:25 pm |
N/A 2024-01-13 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
134,153 | $0 | 81,682 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
29,835 | $9.85 | 81,682 (Direct) |
View |
| 2023-06-01 Tax Withholding |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
22,605 | $38.53 | 81,682 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
9,318 | $7.69 | 81,682 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
95,000 | $17.76 | 81,682 (Direct) |
View |
| 2023-05-31 Tax Withholding |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
29,309 | $38.37 | 81,682 (Direct) |
View |